• Reference Citation Analysis
  • v
  • v
  • Find an Article
Download
Number Select Citation Analysis of Nuri Faruk Aykan's Published Articles
1 Akarca US, Unsal B, Sezgin O, Yalcin K, Akdogan M, Gonen C, Gunduz F, Ozenirler S, Sonsuz A, Dincer D, Tekin SB, Yucel I, Akbulut H, Alkım C, Ozyilkan O, Baygul A, Cevik ZM, Idilman R, Study Group OBOKR. Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study. Turk J Gastroenterol 2021;32:1019-28. [PMID: 34876392 DOI: 10.5152/tjg.2021.201171] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
2 Beypinar I, Demir H, Araz M, Baykara M, Aykan NF. The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer. J Gastrointest Cancer 2020. [PMID: 33159235 DOI: 10.1007/s12029-020-00542-5] [Cited by in Crossref: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
3 Yalcin S, Dane F, Oksuzoglu B, Ozdemir NY, Isikdogan A, Ozkan M, Demirag GG, Coskun HS, Karabulut B, Evrensel T, Ustaoglu MA, Ozdemir F, Turna H, Yavuzsen T, Aykan F, Sevinc A, Akbulut H, Yuce D, Hayran M, Kilickap S. Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study. BMC Cancer 2020;20:259. [PMID: 32228512 DOI: 10.1186/s12885-020-06758-9] [Cited by in Crossref: 6] [Cited by in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
4 Dane F, Ozgurdal K, Yalçın Ş, Benekli M, Aykan NF, Yücel İ, Özkan M, Evrensel T, Sevinç A, Coskun HŞ, Sanli UA, Kara IO, Yumuk PF. Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study. BMJ Open 2020;10:e027665. [PMID: 32220908 DOI: 10.1136/bmjopen-2018-027665] [Cited by in Crossref: 2] [Cited by in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
5 Aykan NF, Özatlı T. Objective response rate assessment in oncology: Current situation and future expectations. World J Clin Oncol 2020; 11(2): 53-73 [PMID: 32133275 DOI: 10.5306/wjco.v11.i2.53] [Cited by in CrossRef: 23] [Cited by in RCA: 19] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
6 Artaç M, Korkmaz L, Coşkun HŞ, Dane F, Karabulut B, Karaağaç M, Çabuk D, Karabulut S, Aykan NF, Doruk H, Avcı N, Turhal NS. Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients. J Gastrointest Cancer 2019;50:214-20. [PMID: 29302856 DOI: 10.1007/s12029-017-0047-2] [Cited by in Crossref: 8] [Cited by in RCA: 9] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
7 Korkmaz L, Coşkun HŞ, Dane F, Karabulut B, Karaağaç M, Çabuk D, Karabulut S, Aykan NF, Doruk H, Avcı N, Turhal NS, Artaç M. Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study. Surg Oncol 2018;27:485-9. [PMID: 30217306 DOI: 10.1016/j.suronc.2018.05.032] [Cited by in Crossref: 3] [Cited by in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
8 Gurdal N, Fayda M, Alishev N, Bakir B, Tastekin D, Aykan F, Gezer U, Balik E, Saglam EK, Oral EN, Gulluoglu M, Kizir A. Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers. Tumori 2018;104:266-72. [PMID: 29218690 DOI: 10.5301/tj.5000702] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
9 Engin G, Eraslan S, Kayserili H, Kapran Y, Akman H, Akyuz A, Aykan NF. Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report. World J Radiol 2017; 9(9): 365-370 [PMID: 29098070 DOI: 10.4329/wjr.v9.i9.365] [Cited by in CrossRef: 3] [Cited by in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
10 Artaç M, Coşkun HŞ, Dane F, Karabulut B, Korkmaz L, Karaağaç M, Çabuk D, Karabulut S, Faruk Aykan N, Doruk H, Avcı N, Turhal NS. Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study. J Gastrointest Cancer 2016;47:264-72. [PMID: 27126591 DOI: 10.1007/s12029-016-9823-7] [Cited by in Crossref: 2] [Cited by in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
11 Karabulut S, Usul Afsar C, Karabulut M, Kilic L, Alis H, Kones O, Bilgin E, Faruk Aykan N. Clinical significance of serum interleukin-17 levels in colorectal cancer patients. J BUON 2016;21:1137-45. [PMID: 27837615] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)]
12 Aykan NF, Yalçın S, Turhal NS, Özdoğan M, Demir G, Özkan M, Yaren A, Camcı C, Akbulut H, Artaç M, Meydan N, Uygun K, Işıkdoğan A, Ünsal D, Özyılkan Ö, Arıcan A, Seyrek E, Tekin SB, Manavoğlu O, Özet A, Elkıran T, Dişçi R. Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial). Turk J Gastroenterol 2015;26:145-53. [PMID: 25835113 DOI: 10.5152/tjg.2015.5685] [Cited by in Crossref: 13] [Cited by in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)]
13 Aykan NFRed Meat and Colorectal Cancer. Oncol Rev. 2015;9:288. [PMID: 26779313 DOI: 10.4081/oncol.2015.288] [Cited by in Crossref: 59] [Cited by in RCA: 49] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
14 Karabulut S, Afsar ÇU, Karabulut M, Alış H, Kılıc L, Çikot M, Yasasever CT, Aykan NF. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma. J Gastrointest Cancer 2016;47:47-54. [PMID: 26637231 DOI: 10.1007/s12029-015-9787-z] [Cited by in Crossref: 8] [Cited by in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
15 Karabulut M, Gunaldi M, Alis H, Afsar CU, Karabulut S, Serilmez M, Akarsu C, Seyit H, Aykan NF. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. Clin Transl Oncol 2016;18:160-71. [PMID: 26184725 DOI: 10.1007/s12094-015-1348-1] [Cited by in Crossref: 16] [Cited by in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
16 Karabulut M, Alis H, Afsar CU, Karabulut S, Kocatas A, Oguz H, Aykan NF. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer. Biomed Pharmacother 2015;73:140-6. [PMID: 26211595 DOI: 10.1016/j.biopha.2015.06.010] [Cited by in Crossref: 5] [Cited by in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
17 Aykan NF. Red meat subtypes and colorectal cancer risk. Int J Cancer 2015;137:1788. [PMID: 25846326 DOI: 10.1002/ijc.29547] [Cited by in Crossref: 3] [Cited by in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
18 Has Simsek D, Kuyumcu S, Turkmen C, Sanlı Y, Aykan F, Unal S, Adalet I. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors? J Nucl Med 2014;55:1811-7. [PMID: 25315243 DOI: 10.2967/jnumed.114.142224] [Cited by in Crossref: 58] [Cited by in RCA: 52] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
19 Tastekin D, Kargin S, Karabulut M, Yaldız N, Tambas M, Gurdal N, Tatli AM, Arslan D, Gok AF, Aykan F. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients. Tumour Biol 2014;35:11871-7. [PMID: 25142230 DOI: 10.1007/s13277-014-2429-4] [Cited by in Crossref: 5] [Cited by in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
20 Karabulut S, Duranyıldız D, Tas F, Gezer U, Akyüz F, Serilmez M, Ozgür E, Yasasever CT, Vatansever S, Aykan NF. Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma. Tumour Biol 2014;35:2729-39. [PMID: 24272080 DOI: 10.1007/s13277-013-1360-4] [Cited by in Crossref: 6] [Cited by in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
21 Faruk Aykan N, Yildiz I, Sen F, Kilic L, Keskin S, Ciftci R, Karabulut S, Sakar B, Disci R. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy. Med Oncol 2013;30:679. [PMID: 23921648 DOI: 10.1007/s12032-013-0679-4] [Cited by in Crossref: 18] [Cited by in RCA: 15] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
22 Kilic L, Ordu C, Ekenel M, Yildiz I, Keskin S, Sen F, Gural Z, Asoglu O, Kizir A, Aykan F. Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients? Med Oncol. 2013;30:660. [PMID: 23877872 DOI: 10.1007/s12032-013-0660-2] [Cited by in Crossref: 8] [Cited by in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
23 Grothey A, Cutsem EV, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouché O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz H, Goldberg RM, Sargent DJ, Cihon F, Cupit L, Wagner A, Laurent D. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 2013;381:303-12. [PMID: 23177514 DOI: 10.1016/s0140-6736(12)61900-x] [Cited by in Crossref: 1668] [Cited by in RCA: 1514] [Impact Index Per Article: 185.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
24 Keskin S, Yıldız I, Sen F, Aydogan F, Kilic L, Ekenel M, Saglam S, Sakar B, Disci R, Aykan F. Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC). Clin Transl Oncol 2013;15:403-8. [PMID: 23054756 DOI: 10.1007/s12094-012-0942-8] [Cited by in Crossref: 5] [Cited by in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
25 Pavel ME, Hainsworth JD, Baudin E, Peeters M, Hörsch D, Winkler RE, Klimovsky J, Lebwohl D, Jehl V, Wolin EM, Öberg K, Van Cutsem E, Yao JC. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study. Lancet 2011;378:2005-12. [DOI: 10.1016/s0140-6736(11)61742-x] [Cited by in Crossref: 720] [Cited by in RCA: 603] [Impact Index Per Article: 65.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
26 Tuna S, Dalkilic Calis M, Sakar B, Aykan F, Camlica H, Topuz E. Prognostic significance of the metastatic lymph node ratio for survival in colon cancer. J BUON 2011;16:478-85. [PMID: 22006754] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)]
27 Salepci T, Yazici H, Dane F, Topuz E, Dalay N, Onat H, Aykan F, Seker M, Aydiner A. Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients. J BUON 2009;14:495-9. [PMID: 19810144] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)]
28 Topuz E, Derin D, Can G, Kürklü E, Çınar S, Aykan F, Çevikbaş A, Dişçi R, Durna Z, Şakar B, Saglam S, Tanyeri H, Deniz G, Gürer Ü, Taş F, Guney N, Aydıner A. Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer. Invest New Drugs 2008;26:567-72. [PMID: 18762864 DOI: 10.1007/s10637-008-9171-y] [Cited by in Crossref: 31] [Cited by in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
29 Aykan N, Idelevich E. The role of UFT in advanced gastric cancer. Ann Oncol 2008;19:1045-52. [PMID: 18281263 DOI: 10.1093/annonc/mdn024] [Cited by in Crossref: 6] [Cited by in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
30 Yazar A, Ustüner Z, Sakar B, Kaytan Sağlam E, Camlica H, Aykan F. Adjuvant chemoradiation for patients with adenocarcinoma of the pancreas: an expirence of single institute. Med Oncol 2007;24:384-7. [PMID: 17917086 DOI: 10.1007/s12032-007-0032-x] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
31 Aykan NF. Message-adjusted network (MAN) hypothesis in gastro-entero-pancreatic (GEP) endocrine system. Med Hypotheses 2007;69:571-4. [PMID: 17363176 DOI: 10.1016/j.mehy.2007.01.048] [Cited by in Crossref: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
32 Sakar B, Gumus M, Basaran M, Argon A, Ustuner Z, Ustaoglu M, Saglam S, Guney N, Tenekeci A, Aykan N. XELOX Followed by XELIRI or the Reverse Sequence in Advanced Colorectal Cancer. Oncology 2007;73:298-304. [PMID: 18477855 DOI: 10.1159/000132395] [Cited by in Crossref: 6] [Cited by in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
33 Kurul S, Aykan F, Tas F. Penile metastasis of cutaneous malignant melanoma: a true hematogenous spread?: Case report and review of the literature. Melanoma Res 2006;16:259-61. [PMID: 16718273 DOI: 10.1097/01.cmr.0000215032.15565.cc] [Cited by in Crossref: 8] [Cited by in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
34 Sakar B, Ustuner Z, Karagol H, Aksu G, Camlica H, Aykan NF. Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis. Am J Clin Oncol 2004;27:489-93. [PMID: 15596917 DOI: 10.1097/01.coc.0000136019.94333.09] [Cited by in Crossref: 14] [Cited by in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
35 Sakar B, Karagol H, Gumus M, Basaran M, Kaytan E, Argon A, Ustuner Z, Bavbek SE, Bugra D, Aykan FN. Timing of Death From Tumor Recurrence After Curative Gastrectomy for Gastric Cancer: . Am J Clin Oncol 2004;27:205-9. [PMID: 15057162 DOI: 10.1097/01.coc.0000092703.12189.a2] [Cited by in Crossref: 36] [Cited by in RCA: 35] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
36 Bouzid K, Khalfallah S, Tujakowski J, Piko B, Purkalne G, Plate S, Padrik P, Serafy M, Pshevloutsky E, Boussard B. A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer. Ann Oncol 2003;14:1106-14. [PMID: 12853354 DOI: 10.1093/annonc/mdg288] [Cited by in Crossref: 17] [Cited by in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
37 Topuz E, Basaran M, Saip P, Aydiner A, Argon A, Sakar B, Tas F, Uygun K, Bugra D, Aykan NF. Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study. Am J Clin Oncol 2002;25:619-24. [PMID: 12478012 DOI: 10.1097/00000421-200212000-00019] [Cited by in Crossref: 14] [Cited by in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
38 Alici S, Aykan NF, Sakar B, Bulutlar G, Kaytan E, Topuz E. Colorectal Cancer in Young Patients: Characteristics and Outcome. TOHOKU J EXP MED 2003;199:85-93. [PMID: 12705353 DOI: 10.1620/tjem.199.85] [Cited by in Crossref: 33] [Cited by in RCA: 30] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
39 Tas F, Aykan F, Alici S, Kaytan E, Aydiner A, Topuz E. Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease. Am J Clin Oncol 2001;24:547-50. [PMID: 11801751 DOI: 10.1097/00000421-200112000-00003] [Cited by in Crossref: 81] [Cited by in RCA: 75] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)]
40 Tas F, Faruk Aykan N, Aydiner A, Yasasever V, Topuz E. Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer. Am J Clin Oncol 2001;24:148-9. [PMID: 11319289 DOI: 10.1097/00000421-200104000-00010] [Cited by in Crossref: 9] [Cited by in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
41 Thirion P, Piedbois P, Buyse M, O'Dwyer PJ, Cunningham D, Man A, Greco FA, Colucci G, Köhne CH, Di Constanzo F, Piga A, Palmeri S, Dufour P, Cassano A, Pajkos G, Pensel RA, Aykan NF, Marsh J, Seymour MT; Meta-Analysis Group in Cancer. Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer. Br J Cancer 2001;84:611-20. [PMID: 11237380 DOI: 10.1054/bjoc.2000.1669] [Cited by in Crossref: 20] [Cited by in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
42 Tas F, Aykan NF, Aydiner A, Uygun K, Basaran M, Camlica H, Topuz E. The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival. Am J Clin Oncol. 2000;23:53-57. [PMID: 10683078 DOI: 10.1097/00000421-200002000-00015] [Cited by in Crossref: 9] [Cited by in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
43 Içli F, Celik I, Aykan F, Uner A, Demirkazik A, Ozet A, Ozgüroğlu M, Taş F, Akbulut H, Firat D. A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group. Cancer 1998;83:2475-80. [PMID: 9874451] [Cited by in Crossref: 10] [Cited by in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)]
44 Aydiner A, Onat H, Öztürk N, Aykan F, Inanc S, Topuz E, Dincol K. The efficacy of a five-drug antiemetic combination during chemotherapy regimens containing cisplatin or cyclophosphamide-doxorubicin. J Pain Symptom Manage 1993;8:126-31. [PMID: 8326162 DOI: 10.1016/0885-3924(93)90140-q] [Cited by in Crossref: 2] [Cited by in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
PrevPage 1 of 1 1Next
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA